pharmaceutical investing Boehringer Ingelheim and Lilly announce positive top-line Phase III data results for empagliflozin as adjunct to insulin in type 1 diabetes
Lode Gold Secures MSHA Property ID for Fremont Gold Mine; Advances Reactivation of Historic California Gold Operation
